Adherence to the 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) Cancer Prevention Recommendations and risk of 14 lifestyle-related cancers in the UK Biobank prospective cohort study
Autor
Malcomson, Fiona C.
Parra‑Soto, Solange
Ho, Frederick
Lu, Liya
Celis-Morales, Carlos
Sharp, Linda
Mathers, John
Fecha
2023Resumen
Background
The World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) Cancer Prevention Recommendations are lifestyle-based recommendations which aim to reduce cancer risk. This study investigated associations between adherence, assessed using a standardised scoring system, and the risk of all cancers combined and of 14 cancers for which there is strong evidence for links with aspects of lifestyle in the UK.
Methods
We used data from 94,778 participants (53% female, mean age 56 years) from the UK Biobank. Total adherence scores (range 0–7 points) were derived from dietary, physical activity, and anthropometric data. Associations between total score and cancer risk (all cancers combined; and prostate, breast, colorectal, lung, uterine, liver, pancreatic, stomach, oesophageal, head and neck, ovarian, kidney, bladder, and gallbladder cancer) were investigated using Cox proportional hazard models, adjusting for age, sex, deprivation index, ethnicity, and smoking status.
Results
Mean total score was 3.8 (SD 1.0) points. During a median follow-up of 8 years, 7296 individuals developed cancer. Total score was inversely associated with risk of all cancers combined (HR: 0.93; 95%CI: 0.90–0.95 per 1-point increment), as well as breast (HR: 0.90; 95%CI: 0.86–0.95), colorectal (HR: 0.90; 95%CI: 0.84–0.97), kidney (HR: 0.82; 95%CI: 0.72–0.94), oesophageal (HR: 0.84; 95%CI: 0.71–0.98), ovarian (HR: 0.76; 95%CI: 0.65–0.90), liver (HR: 0.78; 95%CI: 0.63–0.97), and gallbladder (HR: 0.70; 95%CI: 0.53–0.93) cancers.
Conclusions
Greater adherence to lifestyle-based recommendations was associated with reduced risk of all cancers combined and of breast, colorectal, kidney, oesophageal, ovarian, liver, and gallbladder cancers. Our findings support compliance with the Cancer Prevention Recommendations for cancer prevention in the UK.
Fuente
BMC Medicine, 21, 407Link de Acceso
Click aquí para ver el documentoIdentificador DOI
doi.org/10.1186/s12916-023-03107-yColecciones
La publicación tiene asociados los siguientes ficheros de licencia:
Excepto si se señala otra cosa, la licencia de la publicación se describe como Atribución-NoComercial-SinDerivadas 3.0 Chile
Publicaciones relacionadas
Mostrando publicaciones relacionadas por Título, autor o materia.
-
Cytotoxic effect of geranylphenol derivatives in the human breast cancer cell line MDA-MB-231 and gastric cancer cell line MKN74
Espinoza, Luis; Taborga, Lautaro; Araya, Paulina; Delgado-López, Fernando; Zamora-León, Pilar (2020)Background: Previous studies have demonstrated that geranyl metabolites, found mainly in marine organisms, exhibit interesting antimicrobial and antifungal activities. In addition, linear geranyl derivatives have been ...
-
Development of “on-demand” thermo-responsive hydrogels for anti-cancer drugs sustained release: rational design, in silico prediction and in vitro validation in colon cancer models
Carreño, Gustavo; Pereira, Alfredo; Ávila-Salas, Fabián; Marican, Adolfo; Andrade, Fernanda; Roca-Melendres, Maria; Valdés, Oscar; Vijayakumar, Sekar; Schwartz Jr, Simó; Abasolo, Ibane; Rafael, Diana; Durán-Lara, Esteban F. (2021)A rational design accurate based on the use of Statistical Design of the Experiments (DoE) and Molecular Dynamics Simulations Studies allows the prediction and the understanding of thermo-responsive hydrogels prepared ...
-
Preclinical and clinical trials of new treatment strategies targeting cancer stem cells in subtypes of breast cancer
Landeros, Natalia; Castillo, Iván; Pérez-Castro, Ramón (2023)Breast cancer (BC) can be classified into various histological subtypes, each associated with different prognoses and treatment options, including surgery, radiation, chemotherapy, and endocrine therapy. Despite advances ...